Braunschweig, Germany

Stephan Hüttel

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Hüttel. Retrieved from https://idiyas.com/inventor/stephan-hüttel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Stephan Hüttel

Introduction

Stephan Hüttel is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating bacterial infections and malaria. With a total of 3 patents to his name, Hüttel's work is recognized for its potential impact on public health.

Latest Patents

Hüttel's latest patents include innovative compounds that address critical health issues. One of his notable inventions is related to chlorotonil derivatives, which are designed for the treatment or prophylaxis of bacterial infections and malaria. Another significant patent involves cystobactamides, which also aim to combat bacterial infections. These inventions showcase Hüttel's commitment to advancing medical science through innovative solutions.

Career Highlights

Stephan Hüttel is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts his research and development activities. His work at this esteemed institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Hüttel has worked alongside talented colleagues, including Jennifer Herrmann and Kathrin Mohr. Their collaborative efforts have further enhanced the research output and innovation at Helmholtz-Zentrum für Infektionsforschung GmbH.

Conclusion

Stephan Hüttel's contributions to medicinal chemistry through his patents and research are commendable. His innovative work continues to pave the way for advancements in the treatment of infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…